Scott Klarenbach

Dr. Scott Klarenbach, MD, MSc, FRCPC is a Canadian nephrologist. He is co-chair of the AHS COVID-19 Scientific Advisory Group under Alberta Health Services.

Klarenbach received his medical training at the University of Alberta, and completed his Master of Science in Health Economics at the University of York.¹⁾

Klarenbach's professional affiliations include:^{2) 3)}

• Alberta Drug and Therapeutic Evaluation Consortium - Director
• Canadian Organ Replacement Registry Board - President
• Canadian Society of Nephrology - Chair of the Clinical Practice Guideline Committee
• Canadian Task Force on Preventative Health Care - Vice-Chair
• Kidney Health Strategic Clinical Network - Scientific Director
• University of Alberta Department of Medicine - Professor

Klarenbach is Director of the Alberta Real-World Evidence Consortium at the University of Calgary, which conducts pharmacoepidemiologic and pharmacoeconomic research.⁴⁾ In his declaration of interest from June 2022, Klarenbach noted that the success of RWEC “is contingent on industry funding”, though he doesn't receive any honoraria himself.

Klarenbach has published research funded by the Public Health Agency of Canada through the Jewish General Hospital.⁵⁾

Additional grants involving Klarenbach as Principal or co-Principal Investigator have come from:⁶⁾

• Alberta Health Services (AHS)
• Alberta Innovates
• Canadian Agency for Drugs and Technology in Health (CADTH)
• Canadian Institutes of Health Research (CIHR)
• Institute of Health Economics (IHE)
• Interdisciplinary Chronic Disease Collaboration (ICDC)
• Kidney Health Research Group (KHRG)
• Lawson Health Research Institute
• University Hospital Foundation (UHF)